Common use of RESPONSIBILITIES OF THE SUBRECIPIENT Clause in Contracts

RESPONSIBILITIES OF THE SUBRECIPIENT. A. Case Management and Treatment The SUBRECIPIENT shall increase the proportion of: 1. Patients whose diagnosis is likely to be ATBD who are started on the recommended initial 4-drug regimen. 2. TB patients with positive AFB sputum-smear results who initiate treatment within seven days of specimen collection. 3. TB patients ages 12 years or older with a pleural or respiratory site of disease who have a sputum culture reported. 4. TB patients with positive sputum culture results who have documented conversion to negative results within 60 days of treatment initiation. 5. Patients with newly diagnosed ATBD for whom 12 months or less of treatment is indicated who complete treatment within 12 months. 6. TB patients who have a HIV test result reported. 7. TB patients that complete treatment via Directly Observed Therapy. B. Contact Investigations The SUBRECIPIENT shall increase the proportion of: 1. TB patients with positive AFB sputum-smear results who have contacts elicited. 2. Contacts to sputum AFB smear-positive TB cases who are examined for infection and disease. 3. Contacts to sputum AFB smear-positive TB cases diagnosed with LTBI who start treatment. 4. Contacts to sputum AFB smear-positive TB cases diagnosed with LTBI who complete treatment. C. Examination of Immigrants and Refugees The SUBRECIPIENT shall: 1. Increase the proportion of immigrants and refugees with abnormal chest radiographs read overseas as consistent with TB who: a) Initiate a medical examination within 30 days of notification. b) Complete a medical examination within 90 days of notification. c) Are diagnosed with LTBI or have radiographic findings consistent with prior pulmonary TB on the basis of the examination in U.S. for whom treatment was recommended start treatment. d) Are diagnosed with LTBI or have radiographic findings consistent with prior pulmonary TB on the basis of the examination in U.S. for whom treatment was recommended complete treatment.

RESPONSIBILITIES OF THE SUBRECIPIENT. A. Case Management and Treatment The SUBRECIPIENT shall increase the proportion of: 1. Patients whose diagnosis is likely to be ATBD who are started on the recommended initial 4-drug regimen. 2. TB patients with positive AFB sputum-smear results who initiate treatment within seven days of specimen collection. 3. TB patients ages 12 years or older with a pleural or respiratory site of disease who have a sputum culture reported. 4. TB patients with positive sputum culture results who have documented conversion to negative results within 60 days of treatment initiation. 5. Patients with newly diagnosed ATBD for whom 12 months or less of treatment is indicated who complete treatment within 12 months. 6. TB patients who have a HIV test result reported. 7. TB patients that complete treatment via Directly Observed Therapy. B. Contact Investigations The SUBRECIPIENT shall increase the proportion of: 1. TB patients with positive AFB sputum-smear results who have contacts elicited. 2. Contacts to sputum AFB smear-positive TB cases who are examined for infection and disease. 3. Contacts to sputum AFB smear-positive TB cases diagnosed with LTBI who start treatment. 4. Contacts to sputum AFB smear-positive TB cases diagnosed with LTBI who complete treatment. C. Examination of Immigrants and Refugees The SUBRECIPIENT shall: 1. Increase the proportion of immigrants and refugees with abnormal chest radiographs read overseas as consistent with TB who: a) Initiate a medical examination within 30 days of notification. b) Complete a medical examination within 90 days of notification. c) Are diagnosed with LTBI or have radiographic findings consistent with prior pulmonary TB on the basis of the examination in the U.S. for whom treatment was recommended start treatment. d) Are diagnosed with LTBI or have radiographic findings consistent with prior pulmonary TB on the basis of the examination in the U.S. for whom treatment was recommended complete treatment.

RESPONSIBILITIES OF THE SUBRECIPIENT. A. Case Management and Treatment The SUBRECIPIENT shall increase the proportion of: 1. Patients whose diagnosis is likely to be ATBD who are started on the recommended initial 4-drug regimen. 2. TB patients with positive AFB sputum-smear results who initiate treatment within seven days of specimen collection. 3. TB patients ages 12 years or older with a pleural or respiratory site of disease who have a sputum culture reported. 4. TB patients with positive sputum culture results who have documented conversion to negative results within 60 days of treatment initiation. 5. Patients with newly diagnosed ATBD for whom 12 months or less of treatment is indicated who complete treatment within 12 months. 6. TB patients who have a HIV test result reported. 7. TB patients that complete treatment via Directly Observed TherapyDOT. B. Contact Investigations The SUBRECIPIENT shall increase the proportion of: 1. TB patients with positive AFB sputum-smear results who have contacts elicited. 2. Contacts to sputum AFB smear-positive TB cases who are examined for infection and disease. 3. Contacts to sputum AFB smear-positive TB cases diagnosed with LTBI who start treatment. 4. Contacts to sputum AFB smear-positive TB cases diagnosed with LTBI who complete treatment. C. Examination of Immigrants and Refugees The SUBRECIPIENT shall: 1. Increase the proportion of immigrants and refugees with abnormal chest radiographs read overseas as consistent with TB who: a) Initiate a medical examination within 30 days of notification. b) Complete a medical examination within 90 days of notification. c) Are diagnosed with LTBI or have radiographic findings consistent with prior pulmonary TB on the basis of the examination in U.S. for whom treatment was recommended start treatment. d) Are diagnosed with LTBI or have radiographic findings consistent with prior pulmonary TB on the basis of the examination in U.S. for whom treatment was recommended complete treatment.